NYSE:RCUS

Arcus Biosciences Inc. Stock Predictions

New York Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$15.70

+0.200 (+1.29%)

At Close: May 03, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for RCUS

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	16.72	6.50 %
		R2	16.39	4.38 %
		R1	16.18	3.07 %
Current price:			15.70
	Support	S1	15.52	-1.16 %
		S2	15.31	-2.47 %
		S3	14.98	-4.59 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	19.01	21.08 %
		R2	16.60	5.73 %
		R1	16.41	4.52 %
Current price			15.70
	Support	S1	15.50	-1.27%
		S2	15.27	-2.74%
		S3	14.84	-5.48%

RCUS Predictions History

2 years ago
JS predicted that RCUS for 2021-09-20 is going $37.48 (6.75%)

2 years ago
AlexVel predicted that RCUS for 2021-09-20 is going $36.23 (3.19%)

4 years ago
JS predicted that RCUS for 2020-03-09 is going $19.45 (8.06%)

4 years ago
ErisK predicted that RCUS for 2020-03-09 is going

Rank:

About Arcus Biosciences Inc.

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company also develops Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Pha... RCUS Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In